Literature DB >> 20137882

A common polymorphism in CD40 Kozak sequence (-1C/T) is associated with acute coronary syndrome.

Caixia Tian1, Weichao Qin, Lian Li, Weidong Zheng, Fangcheng Qiu.   

Abstract

OBJECTIVE: Evidence suggests the CD40-CD40L pathway as a key process in the development, progression, and outcome of acute coronary syndrome (ACS). We hypothesized that the -1C/T polymorphism of the CD40 gene would be associated with ACS and influence the CD40 expression.
METHODS: The genotype distribution and allele frequency of CD40-1C/T polymorphism in 248 ACS patients and 206 controls were analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Monocytes from 90 healthy volunteers were incubated with IFN-gamma. CD40 expression was detected by flow cytometry. RESULT: Patients with ACS showed a significant increase of CD40 expression compared with controls (P<0.001). The frequency of the CC genotype in the ACS group was significantly higher than that of the controls (P<0.001). Frequency of the C allele was higher among ACS patients compared with controls (P<0.001). Case control association analysis of the CD40 -1C/T SNP showed an association between the C allele and ACS (OR=1.991, 95%CI: 1.526 approximately 2.596, P<0.001). -1C/C carriers presented significantly higher CD40 expression levels than -1C/T and -1T/T subjects, both in ACS group and controls (P<0.001). When stimulated by IFN-gamma, CD40 expression levels on monocytes in individuals with CC, CT and TT genotypes were increased by 9.16, 3.83 and 1.53 fold, respectively, compared with the levels absent with IFN-gamma.
CONCLUSIONS: These results suggest that the -1C allele of the CD40 (-1C/T) gene polymorphism is a genetic factor that may determine an individual's susceptibility by ACS in Chinese. The CD40 -1C/T polymorphism is a novel regulator of CD40 expression. Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20137882     DOI: 10.1016/j.biopha.2009.09.021

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  10 in total

1.  The association of CD40 polymorphism (rs1883832C/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients.

Authors:  Taghreed G Mousa; Hanan H Omar; Rasha Emad; Mona I Salama; Waleed Omar; Mohamed Fawzy; Howayda M Hassoba
Journal:  Clin Rheumatol       Date:  2018-10-29       Impact factor: 2.980

2.  A SNP in 5' untranslated region of CD40 gene is associated with an increased risk of ischemic stroke in a Chinese population: a case-control study.

Authors:  Hua-Tuo Huang; Jing Guo; Yang Xiang; Jian-Ming Chen; Hong-Cheng Luo; Lan-Qing Meng; Ye-Sheng Wei
Journal:  Genet Mol Biol       Date:  2017-06-05       Impact factor: 1.771

3.  Single nucleotide polymorphisms in the CD40 gene associate with the disease susceptibility and severity in knee osteoarthritis in the Chinese Han population: a case-control study.

Authors:  Zhen-Han Deng; Ming-Hua Sun; Yu-Sheng Li; Wei Luo; Fang-Jie Zhang; Jian Tian; Ping Wu; Wen-Feng Xiao
Journal:  BMC Musculoskelet Disord       Date:  2017-03-21       Impact factor: 2.362

4.  The CD40 rs1883832 Polymorphism Affects Sepsis Susceptibility and sCD40L Levels.

Authors:  Zuo-Liang Liu; Jing Hu; Xue-Fei Xiao; Yue Peng; Shang-Ping Zhao; Xian-Zhong Xiao; Ming-Shi Yang
Journal:  Biomed Res Int       Date:  2018-03-26       Impact factor: 3.411

5.  Analysis of Genetic Variation in CD40 and CD40L: Relationship with mRNA Relative Expression and Soluble Proteins in Acute Coronary Syndrome.

Authors:  D E Martínez-Fernández; J R Padilla-Gutiérrez; F Casillas-Muñoz; Emmanuel Valdés-Alvarado; Brenda Parra-Reyna; Maricela Aceves-Ramírez; J F Muñoz-Valle; U Zalapa Flores; J C Chávez Herrera; Y Valle
Journal:  J Immunol Res       Date:  2019-04-30       Impact factor: 4.818

6.  Genetic Variations of CD40 and LTβR Genes Are Associated With Increased Susceptibility and Clinical Outcome of Non-Small-Cell Carcinoma Patients.

Authors:  Foteinos-Ioannis D Dimitrakopoulos; Anna G Antonacopoulou; Anastasia E Kottorou; Melpomeni Kalofonou; Nikolaos Panagopoulos; Dimitrios Dougenis; Thomas Makatsoris; Vasiliki Tzelepi; Angelos Koutras; Haralabos P Kalofonos
Journal:  Front Oncol       Date:  2021-09-17       Impact factor: 6.244

7.  The SNP rs1883832 in CD40 gene and risk of atherosclerosis in Chinese population: a meta-analysis.

Authors:  Yan Yun; Chi Ma; XiaoChun Ma
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

8.  Genetic Variants of CD40 Gene Are Associated with Coronary Artery Disease and Blood Lipid Levels.

Authors:  Liting Zhou; Lin Xie; Dongchun Zheng; Na Li; Jian Zhu; Shuyue Wang; Bo Li; Lin Ye
Journal:  Biomed Res Int       Date:  2016-04-20       Impact factor: 3.411

9.  Functional genetic variant in the Kozak sequence of WW domain-containing oxidoreductase (WWOX) gene is associated with oral cancer risk.

Authors:  Hsin-Lin Cheng; Yu-Fan Liu; Chun-Wen Su; Shih-Chi Su; Mu-Kuan Chen; Shun-Fa Yang; Chiao-Wen Lin
Journal:  Oncotarget       Date:  2016-10-25

Review 10.  The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease.

Authors:  Laura A Bosmans; Lena Bosch; Pascal J H Kusters; Esther Lutgens; Tom T P Seijkens
Journal:  J Cardiovasc Transl Res       Date:  2020-03-28       Impact factor: 4.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.